
Tianliang Sun, PhD
About Me
Dr. Tianliang Sun has had long-lasting interest in understanding the cell-cell communication during physical or pathological conditions. His current research is centered around the mechanisms of liver regeneration and diseases. Combining state-of-art single cell profiling, spatial transcriptomics, lineage tracing and organoid CRISPR screening, he investigates the plasticity and heterogeneity in multicellular dynamics during liver homeostasis, regeneration and diseases progression.
To learn more about the Sun Lab, please visit our website: http://www.tianliangsunlab.com/
Language
English
Position
ASSISTANT PROFESSOR | Medicine, Liver Diseases, ASSISTANT PROFESSOR | Stem Cell Biology And Regenerative Medicine
Research Topics
Aging, Autoimmunity, Biomedical Sciences, Cancer, Cancer Genetics, Cell Adhesion, Cell Biology, Cell Division, Cell Motility, Cell Transformation, Cellular Differentiation, Chemotaxis, Chromatin, Computational Biology, DNA Recombination, Developmental Biology, Drug Design and Discovery, Epigenetics, Epithelial Cells, Extracellular Matrix, Fibrosis, Gene Discovery, Gene Expressions, Gene Regulation, Gene Therapy, Gene editing, Genetics, Growth, Growth Factors and Receptors, Image Analysis, Imaging, Inflammation, Integrins, Knockout Mice, Lipid Signaling, Liver, Metabolism, Molecular Biology, Oxidative Phosphorylation, Oxidative Stress, Pharmacology, Protein Degradation, Protein Trafficking & Sorting, Receptors, Regeneration, Stem Cells, Transcriptional Activation and Repression, Transgenic Mice, Tumor Suppressor Genes, Tumorigenesis
Multi-Disciplinary Training Areas
Cancer Biology [CAB], Development Regeneration and Stem Cells [DRS], Disease Mechanisms and Therapeutics (DMT)
Education
Ms, Shanghai Institutes for Biological Science, Chinese Academy of Science
PhD, Max-Planck-Institute for Heart and Lung Research
, Max-Planck-Institute for Heart and Lung Research
, Novartis Institutes for BioMedical Research
Awards
2024
Junior Faculty Award
ASIP
Research
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Sun has not yet completed reporting of Industry relationships.
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.